glutathione level mda mb 468 Frontiers Frontiers | Compounds targeting ferroptosis
Frontiers Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential RSL3 induces ferroptosis by activating the NF B signalling pathway to enhance the chemosensitivity of triple negative breast cancer cells to paclitaxel PMC mir5500_01.jpg The oncoprotein MUC1 facilitates breast cancer progression by promoting Pink1 dependent mitophagy via ATAD3A destabilization Cell Death & Disease Auranofin Suppresses Cancer Cell Invasion by Inhibiting Heparanase 1 Expression via the aPKCNF B Pathway
Pay in 4 interest-free payments of $6.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20




